---
title: "PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient"
date: "2024-04-02T09:27:46.000Z"
publishedDate: "2 avril 2024"
summary: "Protembis has announced the enrolment of the first patient in the PROTEMBO investigational device exemption (IDE) pivotal trial, investigating transcatheter aortic valve implantation (TAVI) procedures with the Protembo cerebral embolic protection (CEP) system. The randomised trial will enrol between 250‒500 patients undergoing TAVI in the USA and Europe with the Protembo system."
importance: ""
sourceUrl: "https://cardiovascularnews.com/protembo-randomised-enrols-first-patient/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-04-02-protembo-randomised-trial-of-three-vessel-cerebral-embolic-protection-device-enrols-first-patient"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/09/ProtEmbo.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/protembo-randomised-enrols-first-patient/"
---

![PROTEMBO randomised trial of three-vessel cerebral embolic protection device enrols first patient](https://cardiovascularnews.com/wp-content/uploads/sites/14/2017/09/ProtEmbo.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/protembo-randomised-enrols-first-patient/*

## L’essentiel

Protembis has announced the enrolment of the first patient in the PROTEMBO investigational device exemption (IDE) pivotal trial, investigating transcatheter aortic valve implantation (TAVI) procedures with the Protembo cerebral embolic protection (CEP) system. The randomised trial will enrol between 250‒500 patients undergoing TAVI in the USA and Europe with the Protembo system.

## Lien source

https://cardiovascularnews.com/protembo-randomised-enrols-first-patient/
